Ethics versus patient needs - the delicate 'rheostat' for stem cell research

Natalie Louise Seach, Veronica Shannon, Richard Lennox Boyd

    Research output: Contribution to journalArticleOther

    Abstract

    The isolation of the first human embryonic stem cell (ESC) line, just over a decade ago,1 provided a remarkable catalyst for a new revolution in medical therapies, with the potential to treat a wide variety of debilitating clinical diseases. ESC technologies have since developed rapidly, but scientists caution that clinical trials are still several years away. However, patient expectations for badly needed treatments are high, placing ever-increasing demands on the ethical and regulatory boundaries and leading to continual public debate and revision of legislation.
    Original languageEnglish
    Pages (from-to)16 - 19
    Number of pages4
    JournalChemistry in Australia
    Volume76
    Issue number2
    Publication statusPublished - 2009

    Cite this